Akeso
All
Newsflash
Article
-
Akeso plummeted 31.8% intraday after its oncology drug ivonescimab was rejected by the U.S. FDA.
Akeso plummeted 31.8% intraday after its oncology drug ivonescimab was rejected by the U.S. FDA.
-
Akeso plummeted 31.8% intraday after its oncology drug ivonescimab was rejected by the U.S. FDA.
Akeso plummeted 31.8% intraday after its oncology drug ivonescimab was rejected by the U.S. FDA.
- No data
Akeso
Svmuu provides news and information related to Akeso, as well as real-time data on Akeso. We provide in-depth analysis and interpretation of the latest Akeso developments, helping investors stay informed about Akeso policy updates. Svmuu is your essential tool for keeping up with the latest Akeso trends! Here, we’ll join you in keeping a close eye on Akeso news and use a clear macro perspective to make sense of the uncertain future of crypto.
24H Trending
-
1
ASTER (Aster) dropped 23.56% in 1 hour, currently trading at $0.5225
-
2
ASTER is up 27.87% in the past hour, currently trading at $0.701
-
3
ASTER surged 24.43% in the past hour, currently trading at $0.6835
-
4
ASTER is up 20.91% in the past hour, currently trading at $0.6632
-
5
ASTER (Aster) rose 10.14% in the past 1 hour, currently trading at $0.6026
-
6
ASTER is up 17.01% in the past hour, currently trading at $0.6412
-
7
ASTER is up 13.26% in the past hour, currently trading at $0.6209
-
8
ASTER (Aster) dropped 20.53% in 5 minutes, currently trading at $0.5442
-
9
ASTER dropped 15.99% in 5 minutes, currently trading at $0.5723
-
10
The Defiant: Bitcoin Falls to Four-Month Low, U.S. Spot Funds See $1.91 Billion Outflows Over Seven Trading Days
Markets Today
Recommended Reading
